These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physician's practice handbook: the law, continuing medical education, distribution of drugs, medical records, principles of medical ethics. Pa Med; 1982 Apr; 85(4):27-58. PubMed ID: 7202178 [No Abstract] [Full Text] [Related]
3. Confidential records are no secret. Edelman S Hospitals; 1979 Jun; 53(11):50, 54. PubMed ID: 428948 [No Abstract] [Full Text] [Related]
4. Drug diversion control systems, medical practice, and patient care. Haislip GR NIDA Res Monogr; 1993; 131():120-31. PubMed ID: 8413522 [No Abstract] [Full Text] [Related]
5. Drug diverting patients & prescription monitoring--both sides of the debate. Freeman J Iowa Med; 2004; 94(5):10-1. PubMed ID: 15560649 [No Abstract] [Full Text] [Related]
6. PADS approach to preventing prescription drug diversion. Ambre JJ NIDA Res Monogr; 1993; 131():141-4. PubMed ID: 8413524 [No Abstract] [Full Text] [Related]
7. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances. Joranson DE NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529 [No Abstract] [Full Text] [Related]
9. The applicability of federal alcohol and drug abuse patient record regulations to patient records containing blood alcohol test results. Chernoff SN; Waller AA Top Health Rec Manage; 1986 Dec; 7(2):73-8. PubMed ID: 10318013 [No Abstract] [Full Text] [Related]
10. Mandatory use of prescription drug monitoring programs. Haffajee RL; Jena AB; Weiner SG JAMA; 2015 Mar; 313(9):891-2. PubMed ID: 25622279 [No Abstract] [Full Text] [Related]
11. [Administration of drugs in emergency medical care]. Weise G Z Arztl Fortbild (Jena); 1989; 83(13):681-2. PubMed ID: 2781831 [No Abstract] [Full Text] [Related]
12. Regulation of psychopharmacological medications in nursing homes. Kidder SW J Am Med Dir Assoc; 2005; 6(6):425-6. PubMed ID: 16286072 [No Abstract] [Full Text] [Related]
13. ASHP technical assistance bulletin on institutional use of controlled substances. Am J Hosp Pharm; 1987 Mar; 44(3):580-9. PubMed ID: 3565417 [No Abstract] [Full Text] [Related]
14. Too dangerous not to regulate. Moskos P US News World Rep; 2008 Aug 4-11; 145(3):8. PubMed ID: 18756662 [No Abstract] [Full Text] [Related]
16. Making it easier to read prescriptions. Farley D FDA Consum; 1995; 29(6):25-7. PubMed ID: 10143448 [No Abstract] [Full Text] [Related]
17. A bad trip: lawmakers try to stay one step ahead of the chemists manufacturing dangerous synthetic drugs. Lawrence A State Legis; 2011 Jun; 37(6):28-9. PubMed ID: 21667572 [No Abstract] [Full Text] [Related]
18. Decreasing use of controlled-release oxycodone: response to Morden et al, June 2008 Medical Care. Katz MH; Kotabe S Med Care; 2008 Sep; 46(9):1002. PubMed ID: 18725857 [No Abstract] [Full Text] [Related]
19. What action for rational drug use? Khan I World Health Forum; 1997; 18(1):83-6. PubMed ID: 9233081 [TBL] [Abstract][Full Text] [Related]
20. Drug bazaar: getting medicine off the Web is easy, but dangerous. Fischman J US News World Rep; 1999 Jun; 126(24):58-62. PubMed ID: 10538325 [No Abstract] [Full Text] [Related] [Next] [New Search]